Accessibility Menu
Elixxer logo

Elixxer(OTC) ELIXF

Current Price$0.03
Market Cap$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-98%
1 Year+449%
1 Month+0%
Elixxer last closing stock price
MetricPriceDate
Last closeUSD 0.032026-05-19
Elixxer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.032026-01-23
1 month+0%USD 0.032026-01-23
3 month+0%USD 0.032026-01-23
Year to date+199.11%USD 0.012025-12-30
1 year+449.18%USD 0.012025-03-28
3 year+1.82%USD 0.032023-04-24
5 year-97.77%USD 1.502021-05-20
Since inception-99.91%USD 36.852017-12-14

Elixxer Financials at a Glance

Market Cap

$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$3.87M

EPS (TTM)

-$0.25

P/E Ratio

-0.14

Dividend

$0.00

Beta (Volatility)

-1.04 (Low)

Price

$0.03

Volume

1

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Jul 27, 2026

ELIXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elixxer

Elixxer Ltd. is an investment company focused on the cannabis industry, strategically deploying capital into licensed businesses involved in the cultivation and sale of medicinal cannabis. The company operates across multiple countries, including Canada, Australia, Italy, Jamaica, and Switzerland.

Products and Services
  • Investment in fully licensed cannabis cultivation and production businesses
  • Focus on medicinal and specialized cannabis products
  • Engagement in cannabis-derived product sales for the pharmaceutical sector
Growth Outlook
  • Expansion into international markets enhances revenue potential
  • Increasing global acceptance of cannabis products supports industry growth
  • Strategic partnerships may lead to new investment opportunities
Financial Highlights
  • Recent quarterly net income of -$1,935,367 indicates ongoing operational challenges
  • Trailing twelve months (TTM) cash flow from operations remains negative
  • Current ratio of 0.0044 suggests liquidity concerns
Elixxer Ltd. operates in a rapidly evolving sector, with the cannabis industry experiencing significant growth due to increasing legalization and acceptance. The company's focus on medicinal cannabis positions it well to capitalize on this trend. However, recent financial results indicate challenges, including negative net income and liquidity issues, which potential investors should consider. The company's strategic investments and international reach may provide avenues for future growth, but careful evaluation of financial health is essential.
AI Generated • Jul 11, 2026

Industry

Capital Markets

CEO

Karim Mecklai

Headquarters

Toronto, ON H5B 4N4, CA

ELIXF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

29.22%

Return on Capital

N/A

Return on Assets

-364.36%

Earnings Yield

-7.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

95.26M

Volume

1

Avg. Volume

0.016

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

-CA$666.66K

EBITDA

-CA$665.38K

Operating Cash Flow

-CA$704.96K

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$704.96K

Cash & ST Invst.

CA$35.09K

Total Debt

CA$9.87M

Elixxer Performance Analysis

Elixxer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 0N/A
20232023-12-31CAD 0N/A
20242024-12-31CAD 0N/A
20252025-12-31CAD 0N/A
Elixxer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31N/A
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Elixxer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.97193.0%
20232023-12-31CAD -0.26-73.1%
20242024-12-31CAD -0.22-14.8%
20252025-12-31CAD -0.249.6%
Elixxer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-3164.3%
Q22025-06-30-9.8%
Q32025-09-30-27.5%
Q42025-12-31-142.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

CA$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-CA$1.94M

-22.7%

EBITDA

-CA$326.64K

+70.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$35.09K

+72.9%

Total Debt

CA$9.87M

-17.2%

Accounts Receivable

CA$0.00

-100.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$9.87M

-17.2%

Return on Assets

-3.64%

N/A

Return on Invested Capital

6.64%

N/A

Free Cash Flow

-CA$263.75K

N/A

Operating Cash Flow

-CA$263.75K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DXBRFBellRock Brands Inc.
$0.00+0.00%
TCNAFTransCanna Holdings Inc.
$0.00+0.00%
FLOOFFlower One Holdings Inc.
$0.00+0.00%
SNNVFSunniva Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
TAT&T
$24.13+0.05%

Questions About ELIXF

What is the current price of Elixxer?

Elixxer is trading at $0.03 per share.

What is the 52-week range for Elixxer?

Over the past 52 weeks, Elixxer has traded between $0.00 and $0.10.

How much debt does Elixxer have?

As of the most recent reporting period, Elixxer reported total debt of CA$7.21M.

How much cash does Elixxer have on hand?

Elixxer reported CA$25.62K in cash and cash equivalents in its most recent financial results.

What is Elixxer’s dividend yield?

Elixxer does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.